Chemistry and clinical biology of the bryostatins
- 14 August 2000
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 8 (8) , 1841-1860
- https://doi.org/10.1016/s0968-0896(00)00150-4
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping ruleEuropean Journal Of Cancer, 1999
- Molecular Basis for Protein Kinase C Isozyme-Selective Binding: The Synthesis, Folding, and Phorbol Ester Binding of the Cysteine-Rich Domains of All Protein Kinase C IsozymesJournal of the American Chemical Society, 1998
- An approach to the C(17)–C(24) fragment of bryostatins: applications of stereoselective trisubstituted alkene formation by palladium(0) catalysed coupling of enol acetates and vinylic bromidesJournal of the Chemical Society, Perkin Transactions 1, 1998
- Bcl-2 Phosphorylation Required for Anti-apoptosis FunctionJournal of Biological Chemistry, 1997
- Identification, Cloning, and Sequence of a Major Allergen (Hev b 5) from Natural Rubber Latex (Hevea brasiliensis)Journal of Biological Chemistry, 1996
- An Improved Source of Bryostatin 10, Bugula neritina from the Gulf of Aomori, JapanJournal of Natural Products, 1995
- Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol esterPublished by Elsevier ,1995
- Antineoplastic agents. 126. Isolation and structure of bryostatins 12 and 13The Journal of Organic Chemistry, 1987
- Antineoplastic agents. 119. Isolation and structure of bryostatins 10 and 11The Journal of Organic Chemistry, 1987
- Structure of bryostatin. 4. An important antineoplastic constituent of geographically diverse Bugula neritina (Bryozoa)Journal of the American Chemical Society, 1984